-
Management attributes the strong performance in 2025 to a “flywheel” model in which more than 80% of net sales originate from Autoship, providing a resilient, non-discretionary revenue base.
-
The pet industry is characterized as stable but not accelerated, with growth currently driven by volume rather than prices, as the formation of households with pets remains stable.
-
Strategic focus has shifted to high-margin health and wellness verticals, with Chewy Vet Care (CVC) identified as the company’s fastest spending per customer composite (NSPAC).
-
Operational leverage is being achieved through the launch of the automated Houston Fulfillment Center and structural “cost of service” reductions enabled by a unified data platform.
-
The launch of ‘Chewy Made’ marks a shift toward private label consumables to capture a larger share of the $50 billion to $60 billion food market with higher margins.
-
Management views the emergence of Agentic Commerce as an incremental distribution opportunity rather than a threat due to deep emotional trust in the brand and Chewy’s recurring delivery model.
-
Guidance for 2026 assumes net sales growth of 8% to 9%, based on low single-digit active customer growth and continued NSPAC expansion without reliance on price inflation.
-
Adjusted EBITDA margin is expected to expand by approximately 100 basis points, with a greater proportion of earnings coming from SG&A leverage rather than gross margin compared to 2025.
-
The company anticipates a benefit of “tens of millions” from AI efficiencies in 2026, rising to more than $50 million in annualized savings by 2027.
-
The capital allocation will prioritize increased share buyback activity relative to 2025, supported by record free cash flow and management’s view on current valuation.
-
The SmartEquine acquisition is expected to deliver $80 million in revenue by 2026, with a focus on stabilizing the business before scaling it into a high-margin, multi-hundred-million-dollar category.
-
The transition to a new CFO, Chris Deppe, is intended to provide institutional continuity as the company executes its long-term margin framework.
-
Gross margin expansion is expected to moderate in 2026 as the company overcomes the initial high-growth phase of its sponsored ads business and shifts toward external advertising.
-
Management noted that the SmartEquine business requires “a bit of repair” in 2026, meaning it will not contribute materially to the profit and loss in the immediate term.
-
The company remains debt-free with $1.7 billion in total liquidity, providing a buffer against macroeconomic volatility while funding the expansion of brick-and-mortar veterinary clinics.